Efraim Cohen-Arazi - 18 Mar 2026 Form 3 Insider Report for PRF Technologies Ltd. (PRFX)

Role: Interim CEO, Director
Signature: /s/ Efraim Cohen-Arazi
Issuer symbol: PRFX
Transactions as of: 18 Mar 2026
Net transactions value: $0
Form type: 3
Filing time: 18 Mar 2026, 18:09:44 UTC
SEC: View on sec.gov

Reporting Owners (1)

Name	Relationship	Address	Signature	Signature date	CIK
Cohen-Arazi Efraim	Interim CEO, Director	C/O PRF TECHNOLOGIES LTD., 65 YIGAL ALON ST., TEL AVIV, ISRAEL	/s/ Efraim Cohen-Arazi	18 Mar 2026	0002114591

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
holding	PRFX	Employee Stock Option (Right to Buy)							18 Mar 2026	Ordinary Shares	50	$5400.00	Direct	F1, F2, F3
holding	PRFX	Employee Stock Option (Right to Buy)(1)( 2)							18 Mar 2026	Ordinary Shares	150	$706.80	Direct	F4
holding	PRFX	Employee Stock Option (Right to Buy)(1)( 2)							18 Mar 2026	Ordinary Shares	183	$30.00	Direct	F5
holding	PRFX	Employee Stock Option (Right to Buy)(1)( 2)							18 Mar 2026	Ordinary Shares	3,000	$15.75	Direct	F6

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Options granted under the 2019 PainReform Option Plan.
F2	To qualify for certain tax benefits under Section 102 of the Israeli Tax Ordinance, securities issued to an employee in connection with the 2019 PainReform Option Plan must be registered in the name of a trustee.
F3	The grant date of this grant is February 23, 2021. This option grant is fully vested as of this date.
F4	The grant date of this grant is June 8, 2023. 144 of the options were vested as of the date of appointment. The remaining 6 options will vest on June 8, 2026, subject to the Reporting Person's continued service to the Issuer as of such date.
F5	The grant date of this grant is July 18, 2024. 160 of the options were vested as of the date of appointment. The remaining 23 options will vest in two quarterly installments occurring on April 18, 2026 and July 18, 2026, subject to the Reporting Person's continued service to the Issuer as of each vesting date.
F6	The grant date of this grant is February 20, 2025. 750 of the options were vested as of the date of appointment. The remaining 2,250 options will vest in equal quarterly installments beginning on May 20, 2026 until fully vested on the three-year anniversary of the grant date, subject to the Reporting Person's continued service to the Issuer as of each vesting date.